figshare
Browse
12977_2021_586_MOESM1_ESM.docx (334.39 kB)

Additional file 1 of HIV-2/SIV Vpx antagonises NF-κB activation by targeting p65

Download (334.39 kB)
journal contribution
posted on 2022-01-25, 05:16 authored by Douglas L. Fink, James Cai, Matthew V. X. Whelan, Christopher Monit, Carlos Maluquer de Motes, Greg J. Towers, Rebecca P. Sumner
Additional file 1: Figure S1. Vpx is a broad antagonist of NF-κB. Figure S2. Inhibition of NF-κB is conserved amongst Vpx species variants.

Funding

Wellcome Trust FP7 Ideas: European Research Council Biotechnology and Biological Sciences Research Council

History

Usage metrics

    Retrovirology

    Categories

    Keywords

    VpxNF-κBp65HIV-2SIVImmunomodulator

    Licence

    CC BY + CC0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC